Arabic Arabic English English French French German German
dark

GSK decides to halt mid-stage feladilimab studies

British drugmaker has discontinued treatment with investigational drug in two cancer trials Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder

Next Post

Amylyx Pharma plans to file ALS therapy with the EMA this year

Related Posts
Total
0
Share